Facebook post by University of Helsinki

Twenty years ago, chronic myeloid leukaemia meant a death sentence, with all patients dying within five years of the diagnosis. However, a significant breakthrough made in cancer research in the 1990s changed everything, as researchers were successful in developing a targeted drug therapy for the disease. The next potential advancement in cancer treatment is based on activating the patient’s own immune defence system, says professor Satu Mustjoki. Getting there requires sufficient funding for research. #Researchmatters #Siksitiede
Short-sighted funding for cancer research postpones therapeutic breakthroughs | University of Helsinki helsinki.fi

Satu Mustjoki: Short-sighted funding for cancer research postpones therapeutic breakthroughs